Patent · US Active

Therapeutic uses of anti-GITR antibodies

US12331127B2 · kind B2 · utility

0Cited by
22References
55Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 6, 2023
Grant dateJun 17, 2025
Priority date—
Expiry dateSep 6, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the antibodies or antigen-binding fragments thereof, and methods of using the same, including, e.g., methods of treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.